Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4632 (MIR4632) is a short non-coding RNA molecule of ~20-24 nucleotides, present in humans and encoded by the MIR4632 gene. Like other microRNAs, it regulates gene expression by binding to partially complementary sequences in mRNA targets, leading to mRNA degradation or inhibition of translation. The specific biological functions of MIR4632 have not yet been elucidated, but microRNAs in general act as key regulators of cellular processes, including development, differentiation, and response to external stimuli. Their alteration or dysregulation may correlate with various disease states, making them potential biomarkers or therapeutic targets in emerging RNA-based medicine.
RNA interference: binds complementary sequences in mRNA, leading to mRNA degradation or inhibition of translation. MicroRNA-mediated gene silencing. Modulation of chromatin structure and transcription in some contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4632 (MIR4632).